Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Exactus
AddedFeb 17, 2024
UpdatedJun 18, 2026
Exactus

Exactus

Seed

Next-gen Point-of-Care tech firm, Exactus Inc., innovating rapid, cost-effective diagnostics for improved healthcare.

HQ
Glen Allen, VA, US
Founded
2008
Overview
Compare
Fundraising
Employees

Exactus Inc. is a next-generation Point-of-Care technology firm focused on developing rapid, cost-effective diagnostics for measuring proteolytic enzymes in the blood. Their proprietary detection platform aims to provide physicians with actionable information for better treatment decisions, improved patient outcomes, and long-term healthcare cost reduction.

Exactus Inc. has made significant strides in the Point-of-Care diagnostics market, leveraging their novel technology to enhance medical decision-making. Their innovative approach has positioned them as a key player in the healthcare industry, driving advancements in rapid diagnostics and contributing to more efficient healthcare delivery.

Exactus - Similar Companies

Test Diagnostics logo

Test Diagnostics

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Proxim Diagnostics logo

Proxim Diagnostics

proximdx.com

SenGenix logo

SenGenix

sengenix.com

Instadiagnostics logo

Instadiagnostics

Evanostics logo

Evanostics

Phoresa logo

Phoresa

NAT Diagnostics logo

NAT Diagnostics

Eclipse Diagnostics logo

Eclipse Diagnostics

Dots Technology logo

Dots Technology

dotscorp.com

In Diagnostics logo

In Diagnostics

indiagnostics.com

Exagen logo

Exagen

exagen.com

Prominex logo

Prominex

prominex.com

Perosphere Technologies logo

Perosphere Technologies

perospheretech.com

Empowered Diagnostics logo

Empowered Diagnostics

Exactus - Quick Facts

Who are Exactus' competitors?

Companies similar to Exactus include Test Diagnostics, Prompt Diagnostics, Proxim Diagnostics and SenGenix.

When was Exactus founded?

Exactus was founded in 2008.

Where is Exactus' headquarters located?

Exactus' headquarters is located in Glen Allen, VA, US.

When was Exactus' last funding round?

Exactus' most recent funding round was for $2M (USD) in December 2019.

How much has Exactus raised to-date?

As of Dec 4, 2019, Exactus has raised a total of $4.7M (USD).

How many employees does Exactus have?

Exactus has 7 employees as of Feb 4, 2024.

Exactus - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Healthcare
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 8690Other human health activities
Show 7 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 623000Nursing and Residential Care Facilities
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories